$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-K Financial Statement

#000032001717000008 Filed on March 17, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016
Revenue	$7.923M	$0.00	$35.28M
YoY Change	5.78%	-100.0%	56.9%
Cost Of Revenue	$8.042M		$31.14M
YoY Change	29.12%		54.45%
Gross Profit	-$119.6K		$4.148M
YoY Change	-109.48%		78.11%
Gross Profit Margin	-1.51%		11.76%
Selling, General & Admin	$2.706M	$2.290M	$12.80M
YoY Change	-58.09%	-54.11%	-57.33%
% of Gross Profit			308.67%
Research & Development	$3.726M	$3.200M	$16.70M
YoY Change	-36.59%	1.59%	-30.13%
% of Gross Profit			402.61%
Depreciation & Amortization	$100.0K	$100.0K	$500.0K
YoY Change	-86.49%	-87.5%	-76.19%
% of Gross Profit			12.05%
Operating Expenses	$6.433M	$5.490M	$29.50M
YoY Change	-65.35%	-32.8%	-78.36%
Operating Profit	-$6.433M		-$29.50M
YoY Change	-41.91%		-74.09%
Interest Expense	$158.9K	-$180.0K	$1.780M
YoY Change	-82.85%	-62.5%	-16.39%
% of Operating Profit
Other Income/Expense, Net	-$203.3K	$0.00	-$1.756M
YoY Change	-77.93%	-100.0%	-111.26%
Pretax Income	-$6.636M	-$5.670M	-$31.26M
YoY Change	-44.68%	16963.92%	-68.19%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$9.793M	-$5.960M	-$32.66M
YoY Change	-18.71%	17853.43%	-59.69%
Net Earnings / Revenue	-123.61%		-92.55%
Basic Earnings Per Share			-$4.99
Diluted Earnings Per Share	-$1.116M	-$727.7K	-$4.99
COMMON SHARES
Basic Shares Outstanding	8.308M shares	8.169M shares	6.548M shares
Diluted Shares Outstanding			6.548M shares

Balance Sheet

Concept	2017 Q1	2016 Q4	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.00M	$7.077M	$7.100M
YoY Change	-52.76%	-62.07%	-65.02%
Cash & Equivalents	$12.00M	$7.077M	$7.100M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$6.700M	$17.40M	$17.40M
YoY Change	-11.84%	171.88%	171.88%
Inventory
Prepaid Expenses
Receivables	$3.169M	$138.8K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$21.93M	$24.65M	$24.60M
YoY Change	-38.42%	-15.79%	-16.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.76M	$705.4K	$700.0K
YoY Change	-0.97%	-95.87%	-95.91%
Goodwill	$7.013M	$7.013M
YoY Change	0.0%	0.19%
Intangibles	$2.165M	$2.308M
YoY Change	-20.84%	-19.81%
Long-Term Investments
YoY Change
Other Assets	$655.5K	$1.582M	$28.20M
YoY Change	-26.72%	61.98%	2720.0%
Total Long-Term Assets	$26.59M	$28.87M	$28.90M
YoY Change	-3.53%	3.34%	3.58%
TOTAL ASSETS
Total Short-Term Assets	$21.93M	$24.65M	$24.60M
Total Long-Term Assets	$26.59M	$28.87M	$28.90M
Total Assets	$48.53M	$53.51M	$53.50M
YoY Change	-23.2%	-6.45%	-6.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.578M	$2.227M	$2.200M
YoY Change	-10.21%	-45.79%	-46.34%
Accrued Expenses	$5.062M	$2.659M	$2.700M
YoY Change	-19.95%	-57.1%	-56.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$3.193M	$3.126M	$3.700M
YoY Change	175.58%	-25.05%	-31.48%
Total Short-Term Liabilities	$23.21M	$21.18M	$21.20M
YoY Change	25.72%	0.8%	0.95%
LONG-TERM LIABILITIES
Long-Term Debt	$1.701M	$2.525M	$2.700M
YoY Change	-77.3%	-76.68%	-76.32%
Other Long-Term Liabilities	$407.2K	$389.9K	$6.200M
YoY Change	-5.91%	-30.63%	933.33%
Total Long-Term Liabilities	$2.108M	$28.37M	$8.900M
YoY Change	-73.4%	-16.38%	-25.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.21M	$21.18M	$21.20M
Total Long-Term Liabilities	$2.108M	$28.37M	$8.900M
Total Liabilities	$31.10M	$30.05M	$48.60M
YoY Change	1.64%	-11.42%	45.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$414.1M	-$404.8M
YoY Change	7.82%	8.78%
Common Stock	$8.953K	$8.206K
YoY Change	-84.86%	44.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$707.6K	$707.6K
YoY Change	0.0%	0.0%
Treasury Stock Shares	11.08K shares	11.08K shares
Shareholders Equity	-$791.0K	$4.884M	$4.900M
YoY Change
Total Liabilities & Shareholders Equity	$48.53M	$53.51M	$53.50M
YoY Change	-23.2%	-6.45%	-6.47%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016
OPERATING ACTIVITIES
Net Income	-$9.793M	-$5.960M	-$32.66M
YoY Change	-18.71%	17853.43%	-59.69%
Depreciation, Depletion And Amortization	$100.0K	$100.0K	$500.0K
YoY Change	-86.49%	-87.5%	-76.19%
Cash From Operating Activities	-$10.09M	-$3.380M	-$23.67M
YoY Change	25.65%	-61.28%	-39.71%
INVESTING ACTIVITIES
Capital Expenditures	$69.65K	-$30.00K	$1.099M
YoY Change	-93.33%	-95.16%	-65.49%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$500.0K	-$1.750M
YoY Change		-109.38%	-125.07%
Cash From Investing Activities	-$171.3K	-$530.0K	-$2.849M
YoY Change	-83.61%	-111.23%	-175.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$757.0K		$9.349M
YoY Change	-88.08%
Cash From Financing Activities	$7.552M	0.000	$20.90M
YoY Change	-46.75%	-100.0%	-42.89%
NET CHANGE
Cash From Operating Activities	-$10.09M	-3.380M	-$23.67M
Cash From Investing Activities	-$171.3K	-530.0K	-$2.849M
Cash From Financing Activities	$7.552M	0.000	$20.90M
Net Change In Cash	-$2.707M	-3.910M	-$5.613M
YoY Change	-153.01%	4.83%	-590.53%
FREE CASH FLOW
Cash From Operating Activities	-$10.09M	-$3.380M	-$23.67M
Capital Expenditures	$69.65K	-$30.00K	$1.099M
Free Cash Flow	-$10.16M	-$3.350M	-$24.77M
YoY Change	11.95%	-58.69%	-41.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2016Q4	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2016Q4	clbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	0	USD
CY2016Q4	clbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	0	USD
CY2015	clbs	Business Combination Contingent Consideration Arrangements Changein Amountof Contingent Consideration Change In Fair Value BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationChangeInFairValue	-18260000	USD
CY2016	clbs	Business Combination Contingent Consideration Arrangements Changein Amountof Contingent Consideration Change In Fair Value BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationChangeInFairValue	0	USD
CY2015	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2016	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2015	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	3400000	USD
CY2016	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	6400000	USD
CY2015Q4	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	321404	shares
CY2016Q1	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	141844	shares
CY2015Q4	clbs	Deferred Tax Asset Partnership Interest DeferredTaxAssetPartnershipInterest	0	USD
CY2016Q4	clbs	Deferred Tax Asset Partnership Interest DeferredTaxAssetPartnershipInterest	3857700	USD
CY2015Q4	clbs	Deferred Tax Liabilities Accumulated Depreciation DeferredTaxLiabilitiesAccumulatedDepreciation	66000	USD
CY2016Q4	clbs	Deferred Tax Liabilities Accumulated Depreciation DeferredTaxLiabilitiesAccumulatedDepreciation	649400	USD
CY2015	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	79257	USD
CY2016	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-48697	USD
CY2016	clbs	Interim Efficacy Analysis Followup Milestone Period InterimEfficacyAnalysisFollowupMilestonePeriod	P6M
CY2016	clbs	Interim Efficacy Analysis Percentage Threshold InterimEfficacyAnalysisPercentageThreshold	0.50
CY2015	clbs	Payment For Warrant Inducement PaymentForWarrantInducement	0	USD
CY2016	clbs	Payment For Warrant Inducement PaymentForWarrantInducement	-19400000	USD
CY2015	clbs	Permanent Non Deductible Expenses For Us Taxes PermanentNonDeductibleExpensesForUSTaxes	706400	USD
CY2016	clbs	Permanent Non Deductible Expenses For Us Taxes PermanentNonDeductibleExpensesForUSTaxes	80200	USD
CY2016	clbs	Revene Recognition Period For Cryoperservation Process ReveneRecognitionPeriodForCryoperservationProcess	PT24H
CY2016Q4	clbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	388062	shares
CY2016Q1	clbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.801
CY2016	clbs	Warrants Canceled WarrantsCanceled	105438	shares
CY2016	clbs	Warrants Exercised WarrantsExercised	0	shares
CY2016	clbs	Warrants Expired WarrantsExpired	251	shares
CY2016	clbs	Warrants Granted WarrantsGranted	171845	shares
CY2015	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	26.82
CY2016	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	5.50
CY2016	clbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	152.7
CY2016Q4	clbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	76.50
CY2016	clbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0
CY2016	clbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	700.0
CY2016	clbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	9.3
CY2015Q4	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	137.2
CY2016Q4	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	76.5
CY2016Q4	clbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	76.50
CY2016	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y2M27D
CY2016	clbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P1Y2M27D
CY2015	clbs	Weightedaveragenumberbasicdilutedsharesoutstanding Weightedaveragenumberbasicdilutedsharesoutstanding	4850811	shares
CY2016	clbs	Weightedaveragenumberbasicdilutedsharesoutstanding Weightedaveragenumberbasicdilutedsharesoutstanding	6548251	shares
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8308264	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2016Q2	dei	Entity Public Float EntityPublicFloat	32022091	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	CALADRIUS BIOSCIENCES, INC.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4107388	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4366753	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2566101	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2891723	USD
CY2015	us-gaap	Accretion Expense AccretionExpense	95095	USD
CY2016	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	6874800	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4426800	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6198488	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6062569	USD
CY2015Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	6198400	USD
CY2016Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	6062700	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	480700	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	224500	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7541400	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8417800	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	486	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	396547401	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	410372049	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9750100	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2604400	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	605200	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	570000	USD
CY2015Q4	us-gaap	Assets Assets	57205300	USD
CY2015Q4	us-gaap	Assets Assets	57205295	USD
CY2016Q4	us-gaap	Assets Assets	51832848	USD
CY2016Q4	us-gaap	Assets Assets	51832800	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	29272432	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	24648961	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	4426800	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	4426800	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4426800	USD
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11478600	USD
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	12968400	USD
CY2015Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	445700	USD
CY2016Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	442100	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20318411	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14705008	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	19174061	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	20318411	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	14705008	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1144350	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5613403	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	6875600	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	4426800	USD
CY2016Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.00
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141844	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	5673	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	8206	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-80886795	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32656805	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-124549	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-653214	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-81011344	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-33310019	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	20158828	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	20158800	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	31136100	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	31136129	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2015Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	2911743	USD
CY2016Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	3582298	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14695500	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	109400	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17243500	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	138000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	998700	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1720100	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5345225	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5098193	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4587397	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2548000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	28600	USD
CY2015Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6973000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6988100	USD
CY2015Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	423300	USD
CY2016Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	424200	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1846800	USD
CY2015Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	899700	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11049500	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1300	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	897800	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	107560000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	118471400	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	108558700	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	120191500	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	86537800	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	91455700	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	652100	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	659300	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12764300	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	13747300	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	11100	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	314600	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	297400	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	0	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	932700	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1070700	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	932700	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1070700	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	932662	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1070700	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	800	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0	USD
CY2015	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2686800	USD
CY2016	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2743600	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2686779	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2743648	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2100000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1800000	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-16.67
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.99
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2771200	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	4209700	USD
CY2016Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.199
CY2015Q4	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	6875600	USD
CY2016Q4	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	4426800	USD
CY2015	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-14695500	USD
CY2016	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	109400	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2822100	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3392100	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	570000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	27900	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	570000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	570000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-44300	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-33406400	USD
CY2015	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-124549	USD
CY2016	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-653214	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11278300	USD
CY2016Q4	us-gaap	Goodwill Goodwill	7000000	USD
CY2015	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	62273336	USD
CY2016	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	18200000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	570000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5700000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5700000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2877900	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2307900	USD
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2320900	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2288800	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-591307	USD
CY2015Q4	us-gaap	Goodwill Goodwill	7013315	USD
CY2015Q4	us-gaap	Goodwill Goodwill	7000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	7013315	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98254029	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98254000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33171495	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17243528	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17243500	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138038	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20938600	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4340366	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	344753	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	670555	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-286607	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-262830	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-872990	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6245	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2877880	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2307880	USD
CY2015	us-gaap	Interest Expense InterestExpense	2128400	USD
CY2015	us-gaap	Interest Expense InterestExpense	2128442	USD
CY2016	us-gaap	Interest Expense InterestExpense	1857700	USD
CY2016	us-gaap	Interest Expense InterestExpense	1857694	USD
CY2015	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	1300000	USD
CY2016	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	1700000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4926900	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2702500	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-545173	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	325622	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1011104	USD
CY2015	us-gaap	Interest Paid InterestPaid	1497845	USD
CY2016	us-gaap	Interest Paid InterestPaid	1823424	USD
CY2015	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9750110	USD
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2604291	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1700000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2100000	USD
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2831500	USD
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1753800	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57205295	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51832848	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21015223	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19501299	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33921471	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28366368	USD
CY2016	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	100000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4171456	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3126457	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10828544	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2524897	USD
CY2015Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	583041	USD
CY2016Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	292217	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	68300	USD
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	68300	USD
CY2015	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-843	USD
CY2016	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-486	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	-429709	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-817429	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36604304	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20903575	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3798377	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2849296	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39258331	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23667682	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-80885952	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-32656319	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15595137	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1835737	USD
CY2015Q4	us-gaap	Notes Payable NotesPayable	1800000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	1100000	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	847327	USD
CY2015Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1192666	USD
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2015Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reporting_unit
CY2015	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reporting_unit
CY2015	us-gaap	Operating Expenses OperatingExpenses	136336732	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	66619626	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-113849200	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-113849166	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-31335800	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-31335758	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6232700	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2216300	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	792100	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1332700	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1723500	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	168100	USD
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	221500000	USD
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232700000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2946500	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1628500	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	976768	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	713451	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-843	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-486	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-843	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-486	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	562001	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	389858	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17723579	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21957	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	72010	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6081900	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3185737	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2849296	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3476177	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3469932	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1000000	USD
CY2015	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	36471269	USD
CY2016	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11560394	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1087361	USD
CY2016	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	979579	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	13066014	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-81010501	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-33309533	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24606200	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25566900	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1615742	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	4426800	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-372132490	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-404788809	USD
CY2015	us-gaap	Revenues Revenues	22487600	USD
CY2015	us-gaap	Revenues Revenues	22487566	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17064900	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17149241	USD
CY2015Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	7461200	USD
CY2016Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	8045500	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	0	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	19400000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9348646	USD
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	954326	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23899026	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15108528	USD
CY2015	us-gaap	Restatement Of Prior Year Income Net Of Tax RestatementOfPriorYearIncomeNetOfTax	556500	USD
CY2016	us-gaap	Restatement Of Prior Year Income Net Of Tax RestatementOfPriorYearIncomeNetOfTax	2371600	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	6875600	USD
CY2016	us-gaap	Revenues Revenues	35283900	USD
CY2016	us-gaap	Revenues Revenues	35283868	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30005542	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20374969	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y3M4D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	388062	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	100	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2016Q1	us-gaap	Share Price SharePrice	7.05
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-2548000	USD
CY2016	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	28600	USD
CY2015	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	92800	shares
CY2016	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	126849	shares
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	36471269	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11560394	USD
CY2015	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2488600	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	698100	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9750110	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2532281	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	23713533	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4883909	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58073789	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23283824	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	108492700	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	119542100	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4066480	USD
CY2016Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2016	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-33171500	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	707637	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	707637	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17243528	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-138038	USD
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risks</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to credit risk from our portfolio of cash and cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our services. The majority of our trade accounts receivable arises from services in the United States.</font></div></div>

Files In Submission

Name	View Source	Status
0000320017-17-000008-index-headers.html	Edgar Link	pending
0000320017-17-000008-index.html	Edgar Link	pending
0000320017-17-000008.txt	Edgar Link	pending
0000320017-17-000008-xbrl.zip	Edgar Link	pending
clbs-10kx20161231.htm	Edgar Link	pending
clbs-20161231.xml	Edgar Link	completed
clbs-20161231.xsd	Edgar Link	pending
clbs-20161231_cal.xml	Edgar Link	unprocessable
clbs-20161231_def.xml	Edgar Link	unprocessable
clbs-20161231_lab.xml	Edgar Link	unprocessable
clbs-20161231_pre.xml	Edgar Link	unprocessable
clbs-ex311_20161231xq4.htm	Edgar Link	pending
clbs-ex312_20161231xq4.htm	Edgar Link	pending
clbs-ex32_20161231.htm	Edgar Link	pending
exh1015directorcomppolicy.htm	Edgar Link	pending
exh2112016.htm	Edgar Link	pending
exh2312016.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2017 Q1 Form 10-K Financial Statement

#000032001717000008 Filed on March 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2017 Q1 Form 10-K Financial Statement

#000032001717000008 Filed on March 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta